Cargando…

Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy

INTRODUCTION: Presently used radiochemotherapy regimens result in moderate local control rates for patients with advanced head-and-neck squamous cell carcinoma (HNSCC). Dose escalation (DE) may be an option to improve patient outcome, but may also increase the risk of toxicities in healthy tissue. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakobi, Annika, Lühr, Armin, Stützer, Kristin, Bandurska-Luque, Anna, Löck, Steffen, Krause, Mechthild, Baumann, Michael, Perrin, Rosalind, Richter, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653282/ https://www.ncbi.nlm.nih.gov/pubmed/26636038 http://dx.doi.org/10.3389/fonc.2015.00256

Ejemplares similares

Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes
por: Stützer, Kristin, et al.
Publicado: (2017)

Concept for individualized patient allocation: ReCompare—remote comparison of particle and photon treatment plans
por: Lühr, Armin, et al.
Publicado: (2014)

Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients
por: Bandurska-Luque, Anna, et al.
Publicado: (2019)

PRONTOX – proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
por: Zschaeck, Sebastian, et al.
Publicado: (2016)

Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes
por: Cubillos-Mesías, Macarena, et al.
Publicado: (2017)

Relative biological effectiveness in proton beam therapy – Current knowledge and future challenges
por: Lühr, Armin, et al.
Publicado: (2018)

Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer
por: Stefanowicz, Sarah, et al.
Publicado: (2018)

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
por: Linge, Annett, et al.
Publicado: (2019)

Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo Tumors
por: Rassamegevanon, Treewut, et al.
Publicado: (2018)

Late Side Effects in Normal Mouse Brain Tissue After Proton Irradiation
por: Suckert, Theresa, et al.
Publicado: (2021)

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme
por: Seidlitz, Annekatrin, et al.
Publicado: (2015)

Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy
por: Cordes, Nils, et al.
Publicado: (2018)

Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction
por: Starke, Sebastian, et al.
Publicado: (2023)

Applying Tissue Slice Culture in Cancer Research—Insights from Preclinical Proton Radiotherapy
por: Suckert, Theresa, et al.
Publicado: (2020)

Combined proton radiography and irradiation for high-precision preclinical studies in small animals
por: Schneider, Moritz, et al.
Publicado: (2022)

Normo- or Hypo-Fractionated Photon or Proton Radiotherapy in the Management of Locally Advanced Unresectable Pancreatic Cancer: A Systematic Review
por: Elkhamisy, Sally A., et al.
Publicado: (2023)

Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L
por: Nathansen, Jacqueline, et al.
Publicado: (2021)

Potential margin reduction in prostate cancer proton therapy with prompt gamma imaging for online treatment verification
por: Bertschi, Stefanie, et al.
Publicado: (2023)

Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids
por: Naumann, Max, et al.
Publicado: (2022)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
por: Liebscher, Steffi, et al.
Publicado: (2017)

Specific requirements for translation of biological research into clinical radiation oncology
por: Krause, Mechthild, et al.
Publicado: (2020)

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
por: Linge, Annett, et al.
Publicado: (2016)

Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical
por: Stefanowicz, Sarah, et al.
Publicado: (2020)

Comparison of 3D and 4D robustly optimized proton treatment plans for non-small cell lung cancer patients with tumour motion amplitudes larger than 5 mm
por: Spautz, Saskia, et al.
Publicado: (2023)

Sensitization of Patient-Derived Colorectal Cancer Organoids to Photon and Proton Radiation by Targeting DNA Damage Response Mechanisms
por: Pape, Kristin, et al.
Publicado: (2022)

Prospects for Photon-Photon and Photon-Proton Measurements with Forward Proton Taggers in ATLAS
por: Trzebinski, Maciej
Publicado: (2017)

Prospects for Photon-Photon and Photon-Proton Measurements with Forward Proton Taggers in ATLAS
por: Trzebinski, Maciej
Publicado: (2017)

Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study
por: Ong, Ashley Li Kuan, et al.
Publicado: (2023)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021)

Pediatric Craniospinal Irradiation – The implementation and Use of Normal Tissue Complication Probability in Comparing Photon versus Proton Planning
por: Balasubramanian, S., et al.
Publicado: (2021)

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
por: Meneceur, Sarah, et al.
Publicado: (2020)

Clinical use and future requirements of relative biological effectiveness: survey among all european proton therapy centres
por: Heuchel, Lena, et al.
Publicado: (2022)

Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients—results of KRANIOPHARYNGEOM 2007
por: Friedrich, Carsten, et al.
Publicado: (2023)

Final States in Photon-Photon and Photon-Proton Interactions
por: Soldner-Rembold, Stefan
Publicado: (1998)

Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts
por: Gurtner, Kristin, et al.
Publicado: (2014)

An optimized small animal tumour model for experimentation with low energy protons
por: Beyreuther, Elke, et al.
Publicado: (2017)

The structure of the photon and the proton
por: Caldwell, A
Publicado: (1995)

On the photon constituency of protons
por: De Rujula, A., et al.
Publicado: (1998)

The Photon Content of the Proton
por: Manohar, Aneesh V., et al.
Publicado: (2017)

Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models
por: Shahzadi, Iram, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hbcv9jb0o675ocas39r00587b7